Sage Therapeutics (NASDAQ:SAGE – Free Report) had its price target decreased by TD Cowen from $10.00 to $9.00 in a research note issued to investors on Thursday morning,Benzinga reports.
Several equities research analysts recently weighed in on the company. Mizuho dropped their price target on Sage Therapeutics from $18.00 to $16.00 and set a “neutral” rating on the stock in a ...
Citi raised the firm’s price target on Sage Group (SGPYY) to 1,450 GBp from 1,350 GBp and keeps a Buy rating on the shares. Don't Miss our Black Friday Offers: Published first on TheFly – the ...
Morgan Stanley analyst Vikram Purohit lowered the firm’s price target on Sage Therapeutics (SAGE) to $9 from $11 and keeps an Equal Weight rating on the shares after its Q3 results last week.